Business
Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market
NEW YORK, September 15, 2025--Oscar Health, Inc. ("Oscar") (NYSE: OSCR) today announced its intention to offer, subject to market and other conditions, $350,000,000 aggregate principal amount of convertible senior subordinated notes due 2030 (the "notes") in a private offering (the "Offering") to qualified investors.1 Oscar also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first i
About this update from Oscar Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/8a7b8748c8e76edde8a49a6313e74716"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PDRXjHGyf2hvAi0dTzLJvA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8a7b8748c8e76edde8a49a6313e74716","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/vxjwc8uhpd5i.9sQx.OHBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/8a7b8748c8e76edde8a49a6313e74716","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives as well as the potential extension of enhanced premium tax credits","length":216,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Attractive cost of capital compared to other financing alternatives","length":67,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Expect to use a part of proceeds to purchase a call option on Oscar stock that offsets any share dilution, capped at a 100% premium to the stock price at pricing","length":161,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":444,"olType":false},{"type":"text","content":"NEW YORK, September 15, 2025--(BUSINESS WIRE)--Oscar Health, Inc. ("Oscar") (NYSE: OSCR) today announced its intention to offer, subject to market and other conditions, $350,000,000 aggregate principal amount of convertible senior subordinated notes due 2030 (the "notes") in a private offering (the "Offering") to qualified investors.1 Oscar also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $52,500,000 aggregate principal amount of notes.","length":622,"tagName":"p"},{"type":"text","content":"Oscar intends to use net proceeds from the Offering for general corporate purposes, including to support future expansion fueled by strategic initiatives focused on AI, lowering t...